Life

Biomarkers of nivolumab benefit in resectable non-small cell lung cancer

Nature, Published online: 12 August 2026; doi:10.1038/s41586-026-10925-6Potential predictive biomarkers of perioperative nivolumab therapy benefit in non-small cell lung cancer are identified from evaluable participants in the CheckMate 77T trial.

SINSIN
Aug 13, 2026 - 04:00
 0  6
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer

Nature, Published online: 12 August 2026; doi:10.1038/s41586-026-10925-6Potential predictive biomarkers of perioperative nivolumab therapy benefit in non-small cell lung cancer are identified from evaluable participants in the CheckMate 77T trial.

Read More

Tags:

Previous Article

Superconducting 2D cuprate with a single CuO<sub>2</sub> plane

Next Article

Numerous bow shocks in the outer Helix Nebula

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

SIN
SIN ScienceX Information Network (SIN) | ScienceX Innovations

Related Posts

Why paying peer reviewers works, according to a journal’s editor-in-chief

Why paying peer reviewers works, according to a journal...

SIN Jul 6, 2026  0  23

Numerous bow shocks in the outer Helix Nebula

Numerous bow shocks in the outer Helix Nebula

SIN Aug 13, 2026  0  6

Nobel-winning chemist leaves US to direct AI materials lab in China

Nobel-winning chemist leaves US to direct AI materials ...

SIN Jul 10, 2026  0  26